Hikma Pharmaceuticals (OTCMKTS:HKMPF) Trading Up 3.7% – What’s Next?

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) shares traded up 3.7% on Friday . The stock traded as high as $25.02 and last traded at $25.02. 3,835 shares were traded during trading, an increase of 1,146% from the average session volume of 308 shares. The stock had previously closed at $24.12.

Analysts Set New Price Targets

Separately, Royal Bank of Canada raised shares of Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a research note on Tuesday, December 10th.

Hikma Pharmaceuticals Stock Performance

The company has a debt-to-equity ratio of 0.46, a current ratio of 1.66 and a quick ratio of 0.98. The business has a 50 day moving average price of $24.19 and a 200-day moving average price of $24.81.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.